Analyst reports.

This information is provided for information purposes only. The opinions, estimates, forecasts or any analysis do not represent the opinions, forecasts, or any analysis of our Company or management or staff. We do not by its reference imply any concurrence with the independently provided opinions, estimates or forecasts.

Analyst Reports 2016

Analyst Reports 2016
December 30th 2016

Maxim Group - LAG-3 + Keytruda: Safe So Far - Moving to Higher Dose; Adjusting Model for New ADR Ratio and Reducing Price Target

November 23rd 2016

Maxim Group - Expanding the Footprint in China - WuXi Biologics Comes On Board for Manufacturing of IMP321